ESC 365 - Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy? – discussion.

Open Access

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy? – discussion.

Session: Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy?

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Event: ESC Congress 2021 - The Digital Experience

Congress Session

2 more presentations in this session

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: pro.

Speaker: Doctor R. Al-Lamee (London, GB)

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: con.

Speaker: Doctor D. Holmes (Rochester, US)

Access the full session

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy?

Speakers: Doctor R. Al-Lamee, Doctor D. Holmes

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

Open Access

The optimal patient pathway - how it looks like in our hospital.

28 August 2021

Open Access

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

27 August 2021

Open Access

Colchicine in Acute Myocardial Infarction

27 August 2021

This platform is supported by